Production (Stage)
Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | 219.23M | 254.40M | 271.69M | 256.89M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 219.23M | 254.40M | 271.69M | 256.89M | |
| Cost of Revenue | 153.72M | 175.79M | 188.14M | 186.15M | |
| Gross Profit | 65.50M | 78.61M | 83.55M | 70.73M | |
| SG&A Expenses | 94.64M | 66.06M | 69.80M | 57.50M | |
| Depreciation & Amortization | -39.75M | -- | -- | -- | |
| Other Operating Expenses | 2.15M | -424.80K | -17.60K | 144.40K | |
| Total Operating Expenses | 210.76M | 241.43M | 257.92M | 243.80M | |
| Operating Income | 8.47M | 12.97M | 13.77M | 13.08M | |
| Income Before Tax | 2.56M | 5.87M | 6.90M | 6.47M | |
| Income Tax Expenses | 7.27M | 1.97M | 3.49M | 3.16M | |
| Earnings from Continuing Operations | -4.71M | 3.91M | 3.41M | 3.31M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -4.71M | 3.91M | 3.41M | 3.31M | |
| EBIT | 8.47M | 12.97M | 13.77M | 13.08M | |
| EBITDA | 11.62M | 30.51M | 27.41M | 26.23M | |
| EPS Basic | -0.01 | 0.01 | 0.01 | 0.01 | |
| Normalized Basic EPS | 0.00 | 0.01 | 0.01 | 0.01 | |
| EPS Diluted | -0.01 | 0.01 | 0.01 | 0.01 | |
| Normalized Diluted EPS | 0.00 | 0.01 | 0.01 | 0.01 | |
| Average Basic Shares Outstanding | 408.84M | 408.84M | 408.84M | 408.84M | |
| Average Diluted Shares Outstanding | 408.84M | 408.84M | 408.84M | 408.84M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |